HerbertRudolfNeumanMD

Clinical Trials

• Evaluation of Nephrogenic Systemic Fibrosis (NSF) in Patients With Chronic Kidney Disease Following OptiMARK Injection Start of enrollment: 2009 Feb 01

  Withdrawn

• Fed Study of Chlorpheniramine Polistirex and Hydrocodone Polistirex Capsules and Tussionex® Pennkinetic® Extended Release Oral Suspension Start of enrollment: 2003 Sep 01

  Completed

  Phase 1

• Fasting Study of Oxycodone Hydrochloride 30 mg Tablets and Roxicodone™ 30 mg Tablets Start of enrollment: 2003 Jan 01

  Completed

  Phase 1

• Fed Study of Controlled-Release Oxycodone Hydrochloride 40 mg Tablets and OxyContin® 40 mg Tablets Start of enrollment: 2005 Apr 01

  Completed

  Phase 1

• Fasting Study of Chlorpheniramine Polistirex and Hydrocodone Polistirex Capsules and Tussionex® Pennkinetic® Extended Release Oral Suspension Start of enrollment: 2003 Sep 01

  Completed

  Phase 1

• Fasting Study of Oxycodone Hydrochloride 15 mg Tablets and Roxicodone™ 15 mg Tablets Start of enrollment: 2003 Feb 01

  Completed

  Phase 1

• Fasting Study of Hydromorphone Hydrochloride 8 mg Tablets and Dilaudid 8 mg Tablets Start of enrollment: 2002 Dec 01

  Completed

  Phase 1

• Fed Study of Oxycodone Hydrochloride 30 mg Tablets and Roxicodone™ 30 mg Tablets Start of enrollment: 2003 Feb 01

  Completed

  Phase 1

• Fasting Study of Controlled-Release Oxycodone Hydrochloride 40 mg Tablets and OxyContin® 40 mg Tablets Start of enrollment: 2005 Apr 01

  Completed

  Phase 1

• Study to Evaluate the Effect of Age (Geriatric) and Kidney Function on the Safety, Efficacy and Pharmacokinetics of OctreoScan in Patients Who Have New or Recurrent Tumors Start of enrollment: 2003 Jul 01

  Terminated

  Phase 4

• Bioequivalence of a Test Troche Formulation of Fentanyl Citrate (400 mcg) Compared to Actiq® 400 mcg, Cephalon, Inc. Start of enrollment: 2006 Aug 01

  Completed

  Phase 1

• Join now to see all